Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

HAINAN POLY

  • FDA Approval
  • Dec. 31, 2024, 09:36 UTC
  • 40

FDA approve CYCLOPHOSPHAMIDE

Comment Full text

PHARM ASSOC

  • FDA Approval
  • Dec. 31, 2024, 09:36 UTC
  • 44

FDA approve CHLORHEXIDINE GLUCONATE

Comment Full text

HETERO LABS

  • FDA Approval
  • Dec. 31, 2024, 09:36 UTC
  • 52

FDA approve DROSPIRENONE; ETHINYL ESTRADIOL

Comment Full text

NOVITIUM PHARMA

  • FDA Approval
  • Dec. 31, 2024, 09:36 UTC
  • 38

FDA approve PRUCALOPRIDE SUCCINATE

Comment Full text

RUBICON

  • FDA Approval
  • Dec. 31, 2024, 09:36 UTC
  • 40

FDA approve BUMETANIDE

Comment Full text

AUROBINDO PHARMA

  • FDA Approval
  • Dec. 31, 2024, 09:36 UTC
  • 50

FDA approve TERIFLUNOMIDE

Comment Full text

HALEON US HOLDINGS

  • FDA Approval
  • Dec. 31, 2024, 09:36 UTC
  • 35

FDA approve IBUPROFEN

Comment Full text

FIDELITY BIOPHARMA

  • FDA Approval
  • Dec. 31, 2024, 05:15 UTC
  • 44

FDA approve TIZANIDINE HYDROCHLORIDE

Comment Full text

BOEHRINGER INGELHEIM

  • FDA Approval
  • Dec. 30, 2024, 19:23 UTC
  • 42

FDA approve TIOTROPIUM BROMIDE

Comment Full text

BOEHRINGER INGELHEIM

  • FDA Approval
  • Dec. 30, 2024, 18:52 UTC
  • 35

FDA approve OLODATEROL HYDROCHLORIDE

Comment Full text
  • Previous
  • 165
  • 166
  • 167
  • 168
  • 169
  • Next

Search

News categories

  • Technical Exchange News(9869)
  • Event(407)
  • SEC News(167081)
  • FDA Approval(9320)
  • Company Report(721)
  • Business News(110962)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin